Corium Announces Closing of Follow-On Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 31, 2017 16:02 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Prices Follow-On Offering of Common Stock
May 25, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 24, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Positive Preliminary Results in Alzheimer’s Clinical Study
May 11, 2017 07:02 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights
May 11, 2017 07:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Preliminary Results from Corplex Donepezil Pilot Study and Second Quarter Fiscal 2017 Financial Results Before Market Open on Thursday, May 11, 2017
May 09, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report preliminary results of the Corplex Donepezil pilot bioequivalence...
Corium to Present at the 16th Annual Needham Healthcare Conference
March 27, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Participate in BioPharma Dealmakers Webcast on New Innovations in Drug Delivery Technology
March 22, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., March 22, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Positive Progress in Pilot Bioequivalence Study of Once-Weekly Corplex™ Donepezil Patch
March 20, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., March 20, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports First Quarter Fiscal 2017 Financial Results
February 13, 2017 16:02 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...